Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;13(12):725-734.

Update on Functional Heartburn

Affiliations

Update on Functional Heartburn

Takahisa Yamasaki et al. Gastroenterol Hepatol (N Y). 2017 Dec.

Abstract

The definition of functional heartburn has been refined over the years. It is currently described, based upon Rome IV criteria, as typical heartburn symptoms in the presence of normal upper endoscopy findings (including normal biopsies), normal esophageal pH testing, and a negative association between symptoms and reflux events. Functional heartburn is very common, affecting women more than men, and with reflux hypersensitivity makes up the majority of heartburn patients who fail twice-daily proton pump inhibitor therapy. These disorders overlap with other functional gastrointestinal disorders and are often accompanied by psychological comorbidities. Diagnosis is made by using endoscopy with esophageal biopsies, wireless pH capsule, pH-impedance monitoring, and high-resolution esophageal manometry. Additional diagnostic tools that may be of value include magnification endoscopy, chromoendoscopy, narrow-band imaging, autofluorescence imaging, mucosal impedance, impedance baseline values, and histopathology scores. Functional heartburn is primarily treated with neuromodulators. Psychological intervention and complementary and alternative medicine may also play important roles in the treatment of these patients.

Keywords: Heartburn; esophagus; pH testing; proton pump inhibitor; upper endoscopy.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Classification of patients with normal endoscopy findings and no history of documented gastroesophageal reflux disease (GERD) using Rome IV criteria.
Figure 2.
Figure 2.
Percentage of functional heartburn patients among patients with normal endoscopy findings. Reproduced with permission from Yamasaki T, Fass R.
Figure 3.
Figure 3.
Diagnostic algorithm of functional heartburn in refractory heartburn patients who failed twice-daily proton pump inhibitor therapy. GERD, gastroesophageal reflux disease; MII, multichannel intraluminal impedance; NERD, nonerosive reflux disease. Adapted from Yamasaki T, Fass R.

Similar articles

Cited by

References

    1. Drossman DA, Corazziari R, Talley NJ, et al. Rome II: The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd ed. McLean, VA: Degnon Associates; 2000.
    1. Drossman DA. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates; 2006.
    1. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease—where next? Aliment Pharmacol Ther. 2005;22(2):79–94. - PubMed
    1. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115(6):1363–1373. - PubMed
    1. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262–1279.e2. - PubMed

LinkOut - more resources